Breaking News

Lifecore Biomedical Enters 10-Year Commercial Manufacturing & Supply Agreement

This will support the advancement of a novel ophthalmic therapeutic through clinical development and onto the market.

By: Rachel Klemovitch

Assistant Editor

Lifecore Biomedical (Lifecore), a fully integrated CDMO, has signed a new 10-year commercial manufacturing and supply agreement with a key existing customer. This represents the latest agreement signed between the two companies to support the advancement of a novel ophthalmic therapeutic through clinical development and onto the market. Lifecore has also signed a multi-million-dollar statement of work detailing a range of fill and finish CDMO services that will further advance this program to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters